Drug Shortage Report for VIRACEPT -250MG
| Report ID | 65178 |
| Drug Identification Number | 02238617 |
| Brand name | VIRACEPT -250MG |
| Common or Proper name | Viracept |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NELFINAVIR |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1x300 BTL |
| ATC code | J05AE |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-05-31 |
| Actual start date | 2019-05-31 |
| Estimated end date | 2019-07-05 |
| Actual end date | 2019-07-05 |
| Shortage status | Resolved |
| Updated date | 2019-07-06 |
| Company comments | Distributed by ViiV Healthcare. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-10-22 | English | Compare |
| v2 | 2018-10-22 | English | Compare |
| v3 | 2018-10-22 | French | Compare |
| v4 | 2018-11-14 | English | Compare |
| v5 | 2018-11-14 | French | Compare |
| v6 | 2018-11-29 | English | Compare |
| v7 | 2018-11-29 | French | Compare |
| v8 | 2019-02-20 | English | Compare |
| v9 | 2019-02-20 | French | Compare |
| v10 | 2019-05-01 | English | Compare |
| v11 | 2019-05-09 | English | Compare |
| v12 | 2019-05-09 | French | Compare |
| v13 | 2019-05-16 | English | Compare |
| v14 | 2019-05-16 | French | Compare |
| v15 | 2019-05-21 | English | Compare |
| v16 | 2019-05-21 | French | Compare |
| v17 | 2019-05-31 | English | Compare |
| v18 | 2019-05-31 | French | Compare |
| v19 | 2019-06-01 | English | Compare |
| v20 | 2019-07-05 | English | Compare |